Loading
Loading…
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹37,360Qualified B NO 62 SHAHEED UDHAM SINGH NAGAR JALANDHAR PUNJAB 144001 | JALANDHAR | PUNJAB | 144001 | L1 | Qualified MSE, Category: General | |
| 2 | L2₹51,170+₹13,810 (37.0%)Qualified | L2 | Qualified MSE, Category: General |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
11 Oct 2025, 11:00 amClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
Ciprofloxacin HCl 0 point 3 PERCENT Tube of 5 gm
Gatifloxacin 0 point 3 percent eye drop bott of 5 ml
Gentamicin sulphate 0 point 3 percent Hydrocortisone 1 percent eye drops 5 ml
Ofloxacin 0 point 3 percent bott of 5 ml
Betahistine Dihydrochloride 8mg Tab
Cinnarizine 25 mg Tab
Nasal Decongestant adult drops Xylometazoline HCl 0 point 1 percent nasal drop 10 ml
Xylometazoline HCl 0 point 05 percent nasal solution paed 10ml
Syp Dicyclomine drops of 15 ml
Norflox Syp 100mg per 5ml bott of 30 ml
Triclofos Syp 500 mg per 5ml in 30ml bottle
Ibuprofen 400 mg Tab
Lorazepam 1 mg Tab
Tab Amisulpride 200 mg
Etophylline BP 84 point 7 mg and Theophylline IP 25 point 3 mg per ml 2 ml Inj
Ipratropium Bromide Respirator soln 500 mcg per 2 ml respule
Dextrose 25 percent 25 ml Inj
Alfuzosin 10 mg Tab
Ascorbic Acid 100 mg Tab
8421870
GEM/2025/B/6745456
Two Packet Bid
Ciprofloxacin HCl 0 point 3 PERCENT Tube of 5 gm
21 days
HYDERABAD
Total value wise evaluation
BOQ
5 documents required · 5 mandatory
1 yrs
10%
Exempted
15 Oct 2025
1 Oct 2025
11 Oct 2025
Ciprofloxacin HCl 0 point 3 PERCENT Tube of 5 gm
Gatifloxacin 0 point 3 percent eye drop bott of 5 ml
Gentamicin sulphate 0 point 3 percent Hydrocortisone 1 percent eye drops 5 ml
Ofloxacin 0 point 3 percent bott of 5 ml
Betahistine Dihydrochloride 8mg Tab
Cinnarizine 25 mg Tab
Nasal Decongestant adult drops Xylometazoline HCl 0 point 1 percent nasal drop 10 ml
Xylometazoline HCl 0 point 05 percent nasal solution paed 10ml
Syp Dicyclomine drops of 15 ml
Norflox Syp 100mg per 5ml bott of 30 ml
Triclofos Syp 500 mg per 5ml in 30ml bottle
Ibuprofen 400 mg Tab
Lorazepam 1 mg Tab
Tab Amisulpride 200 mg
Etophylline BP 84 point 7 mg and Theophylline IP 25 point 3 mg per ml 2 ml Inj
Ipratropium Bromide Respirator soln 500 mcg per 2 ml respule
Dextrose 25 percent 25 ml Inj
Alfuzosin 10 mg Tab
Ascorbic Acid 100 mg Tab
Ciprofloxacin HCl 0.3 PERCENT Tube of 5 gm
Gatifloxacin 0.3 percent eye drop bott of 5 ml
Gentamicin sulphate 0.3 percent Hydrocortisone 1 percent eye drops 5 ml
Ofloxacin 0.3 percent bott of 5 ml
Betahistine Dihydrochloride 8mg Tab
Cinnarizine 25 mg Tab
Nasal Decongestant adult drops Xylometazoline HCl 0.1 percent nasal drop 10 ml
Xylometazoline HCl 0.05 percent nasal solution paed 10ml
Syp Dicyclomine drops of 15 ml
Norflox Syp 100mg per 5ml bott of 30 ml
Triclofos Syp 500 mg per 5ml in 30ml bottle
Ibuprofen 400 mg Tab
Lorazepam 1 mg Tab
Tab Amisulpride 200 mg
Etophylline BP 84.7 mg and Theophylline IP 25.3 mg per ml 2 ml Inj
Ipratropium Bromide Respirator soln 500 mcg per 2 ml respule
Dextrose 25 percent 25 ml Inj
Alfuzosin 10 mg Tab
Ascorbic Acid 100 mg Tab
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_8421870.pdf
GEM_BID
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
undertaking-30_2025-10-01-09-18-25_60bb05de40d45d33de76892635fff39b.pdf
BOQ
boq_item_sample_file_2025-10-01-09-18-26_9b77636c0119e70d6341d9a57c53532b.csv.pdf
BOQ
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .